Table 4 The effect of bone turnover markers on the high decline in serum calcium.
From: Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients
Variables | Univariate | Adjusted for age and sex | ||
|---|---|---|---|---|
OR (95% CI) | p value | OR (95% CI) | p value | |
ALP, IU/L | 1.015 (1.0007–1.039) | 0.036 | 1.031 (1.005–1.076) | 0.009 |
BAP, μg/L | 1.202 (1.002–1.741) | 0.044 | 1.747 (1.084–4.604) | 0.007 |
TRACP-5b, mU/dL | 1.004 (0.999–1.010) | 0082 | 1.006 (1.000–1.015) | 0.046 |